Diagnostic value of delta neutrophil index in determining axillary metastases in breast cancer
Abstract
Keywords
References
- Siegal R, Ma J, Zou Z, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2014; 64: 9-29.
- Marín Hernández C, Piñero Madrona A, Gil Vázquez PJ, et al. Usefulness of lymphocyte-to-monocyte, neutrophil-to-monocyte and neutrophil-to-lymphocyte ratios as prognostic markers in breast cancer patients treated with neoadjuvant chemotherapy. Clin Transl Oncol 2018; 20: 476-83.
- Chen F, Liu M, Yu Y, et al. LINC00958 regulated miR-627-5p/YBX2 axis to facilitate cell proliferation and migration in oral squamous cell carcinoma. Cancer Biol Ther 2019; 20: 1270-80.
- Saadatmand S, Bretveld R, Siesling S, Tilanus-Linthorst MM. Influencetumormour stage at breast cancer detection on survival in modern times: population-based study in 173,797 patients. BMJ 2015; 351: 4901.
- Guthrie GJ, Charles KA, Roxburgh CS, et al. The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol 2013; 88: 218-30.
- McMillan DC. Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care 2009; 12: 223-6.
- Templeton AJ, McNamara MG, Šeruga B, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst 2014; 29: 106
- Morris GJ, Naidu S, Topham AK, et al. Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients: a single-institution compilation compared with the National Cancer Institute’s Surveillance, Epidemiology, and End Results database. Cancer 2007; 110: 876-84
Details
Primary Language
English
Subjects
Health Care Administration
Journal Section
Research Article
Publication Date
September 26, 2022
Submission Date
August 16, 2022
Acceptance Date
September 10, 2022
Published in Issue
Year 2022 Volume: 3 Number: 3






